請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/76810
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賴逸儒(I-Rue Lai) | |
dc.contributor.author | Yi-Hung Liu | en |
dc.contributor.author | 劉奕宏 | zh_TW |
dc.date.accessioned | 2021-07-10T21:37:30Z | - |
dc.date.available | 2021-07-10T21:37:30Z | - |
dc.date.copyright | 2020-09-10 | |
dc.date.issued | 2020 | |
dc.date.submitted | 2020-08-18 | |
dc.identifier.citation | 1. de Groot, H. and U. Rauen, Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transplant Proc, 2007. 39(2): p. 481-4. 2. Muzio, M., et al., An induced proximity model for caspase-8 activation. J Biol Chem, 1998. 273(5): p. 2926-30. 3. Li, P., et al., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 1997. 91(4): p. 479-89. 4. Selzner, N., et al., Protective strategies against ischemic injury of the liver. Gastroenterology, 2003. 125(3): p. 917-36. 5. Phillips, L., et al., Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg, 2009. 22(1): p. 46-55. 6. Montalvo-Jave, E.E., et al., Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res, 2008. 147(1): p. 153-9. 7. Llacuna, L., et al., Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion. Am J Pathol, 2009. 174(5): p. 1776-85. 8. Nakano, Y., et al., Platelet dynamics in the early phase of postischemic liver in vivo. J Surg Res, 2008. 149(2): p. 192-8. 9. Taniai, H., et al., Susceptibility of murine periportal hepatocytes to hypoxia-reoxygenation: role for NO and Kupffer cell-derived oxidants. Hepatology, 2004. 39(6): p. 1544-52. 10. Hanschen, M., et al., Reciprocal activation between CD4+ T cells and Kupffer cells during hepatic ischemia-reperfusion. Transplantation, 2008. 86(5): p. 710-8. 11. Banai, S., et al., Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res, 1994. 28(8): p. 1176-9. 12. Warburg, O., et al., [EXPERIMENTS ON ANAEROBIOSIS OF CANCER CELLS]. Klin Wochenschr, 1965. 43: p. 289-93. 13. Kitakaze, M., et al., Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet, 2007. 370(9597): p. 1483-93. 14. Maki, T., et al., Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts. Br J Pharmacol, 2000. 131(6): p. 1204-10. 15. Mewton, N., et al., Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol, 2010. 55(12): p. 1200-1205. 16. Lønborg, J., et al., Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia. Circ Cardiovasc Interv, 2012. 5(2): p. 288-95. 17. Singer, N.G. and A.I. Caplan, Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol, 2011. 6: p. 457-78. 18. McCully, J.D., et al., Injection of isolated mitochondria during early reperfusion for cardioprotection. Am J Physiol Heart Circ Physiol, 2009. 296(1): p. H94-h105. 19. Lin, H.C. and I.R. Lai, Isolated mitochondria infusion mitigates ischemia-reperfusion injury of the liver in rats: reply. Shock, 2013. 39(6): p. 543. 20. Clavien, P.A., et al., A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg, 2003. 238(6): p. 843-50; discussion 851-2. 21. Valadi, H., et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 2007. 9(6): p. 654-9. 22. Simpson, R.J., S.S. Jensen, and J.W. Lim, Proteomic profiling of exosomes: current perspectives. Proteomics, 2008. 8(19): p. 4083-99. 23. Chen, J. and M. Chopp, Exosome Therapy for Stroke. Stroke, 2018. 49(5): p. 1083-1090. 24. He, C., et al., Exosome Theranostics: Biology and Translational Medicine. Theranostics, 2018. 8(1): p. 237-255. 25. Lai, C.P.-K. and X.O. Breakefield, Role of Exosomes/Microvesicles in the Nervous System and Use in Emerging Therapies. Frontiers in Physiology, 2012. 3: p. 228. 26. Pan, T., et al., Delayed Remote Ischemic Preconditioning ConfersRenoprotection against Septic Acute Kidney Injury via Exosomal miR-21. Theranostics, 2019. 9(2): p. 405-423. 27. Murry, C.E., R.B. Jennings, and K.A. Reimer, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986. 74(5): p. 1124-36. 28. DeFily, D.V. and W.M. Chilian, Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am J Physiol, 1993. 265(2 Pt 2): p. H700-6. 29. Petrowsky, H., et al., Liver transplantation for lethal genetic syndromes: a novel model of personalized genomic medicine. J Am Coll Surg, 2013. 216(4): p. 534-43; discussion 543-4. 30. Przyklenk, K., et al., Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation, 1993. 87(3): p. 893-9. 31. Farooqui, W., H.C. Pommergaard, and A. Rasmussen, Remote ischemic preconditioning of transplant recipients to reduce graft ischemia and reperfusion injuries: A systematic review. Transplant Rev (Orlando), 2018. 32(1): p. 10-15. 32. Kambakamba, P., et al., Novel Benefits of Remote Ischemic Preconditioning Through VEGF-dependent Protection From Resection-induced Liver Failure in the Mouse. Ann Surg, 2018. 268(5): p. 885-893. 33. Duan, Y.F., et al., Remote ischemic preconditioning protects liver ischemia-reperfusion injury by regulating eNOS-NO pathway and liver microRNA expressions in fatty liver rats. Hepatobiliary Pancreat Dis Int, 2017. 16(4): p. 387-394. 34. Wolf, P., The nature and significance of platelet products in human plasma. Br J Haematol, 1967. 13(3): p. 269-88. 35. Hessvik, N.P. and A. Llorente, Current knowledge on exosome biogenesis and release. Cell Mol Life Sci, 2018. 75(2): p. 193-208. 36. Ribeiro, M.F., et al., Exosomes Function in Pro- and Anti-Angiogenesis. Curr Angiogenes, 2013. 2(1): p. 54-59. 37. Zhu, H. and G.C. Fan, Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis, 2011. 1(2): p. 138-149. 38. Sluijter, J.P., et al., Microvesicles and exosomes for intracardiac communication. Cardiovasc Res, 2014. 102(2): p. 302-11. 39. Ailawadi, S., et al., Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta, 2015. 1852(1): p. 1-11. 40. Hoshino, A., et al., Tumour exosome integrins determine organotropic metastasis. Nature, 2015. 527(7578): p. 329-35. 41. Selmaj, I., et al., Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol, 2017. 81(5): p. 703-717. 42. Li, Y., et al., Role of exosomes induced by remote ischemic preconditioning in neuroprotection against cerebral ischemia. Neuroreport, 2019. 30(12): p. 834-841. 43. Jung, K.W., et al., Effect of Remote Ischemic Preconditioning Conducted in Living Liver Donors on Postoperative Liver Function in Donors and Recipients Following Liver Transplantation: A Randomized Clinical Trial. Ann Surg, 2020. 271(4): p. 646-653. 44. Zarbock, A., H. Van Aken, and C. Schmidt, Remote ischemic preconditioning and outcome: shall we all have an intermittent tourniquet? Curr Opin Anaesthesiol, 2015. 28(2): p. 165-71. 45. Lai, I.R., et al., Transient limb ischemia induces remote preconditioning in liver among rats: The protective role of heme oxygenase-1. Transplantation, 2006. 81(9): p. 1311-1317. 46. Meirelles Júnior, R.F., et al., Liver transplantation: history, outcomes and perspectives. Einstein (Sao Paulo), 2015. 13(1): p. 149-52. 47. Haraszti, R.A., et al., High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles, 2016. 5: p. 32570. 48. <Expression of Heat Shock Protein 70 in Rat Spleen Lymphocytes is Affected by Age but Not by Food Restriction1'2 .pdf>. 49. Gero, D., The Hypoxia-Reoxygenation Injury Model. 2017. 50. Zhang, G., et al., Comparative Analysis of microRNA Expression Profiles of Exosomes Derived from Normal and Hypoxic Preconditioning Human Neural Stem Cells by Next Generation Sequencing. J Biomed Nanotechnol, 2018. 14(6): p. 1075-1089. 51. Björnsson, B., et al., Conventional, but not remote ischemic preconditioning, reduces iNOS transcription in liver ischemia/reperfusion. World J Gastroenterol, 2014. 20(28): p. 9506-12. 52. Tang, Y., et al., MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J, 2009. 50(3): p. 377-87. 53. Chi, X., et al., Suppression of microRNA‑27a protects against liver ischemia/reperfusion injury by targeting PPARγ and inhibiting endoplasmic reticulum stress. Mol Med Rep, 2019. 20(5): p. 4003-4012. 54. Leelahavanichkul, A., et al., Serum miRNA-122 in acute liver injury induced by kidney injury and sepsis in CD-1 mouse models. Hepatol Res, 2015. 45(13): p. 1341-52. 55. Lai, I.R., et al., The protective role of heme oxygenase-1 on the liver after hypoxic preconditioning in rats. Transplantation, 2004. 77(7): p. 1004-8. 56. Roderburg, C., et al., Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int, 2015. 35(4): p. 1172-84. 57. Fathi-Kazerooni, M., et al., Down-regulation of miR-122 after transplantation of mesenchymal stem cells in acute liver failure in mice model. Biologicals, 2019. 58: p. 64-72. 58. Van Caster, P., et al., Circulating microRNA-122, -21 and -223 as potential markers of liver injury following warm ischaemia and reperfusion in rats. Mol Med Rep, 2015. 12(2): p. 3146-50. 59. Abe, Y., et al., Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med, 2009. 46(1): p. 1-7. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/76810 | - |
dc.description.abstract | 前言:最近發現外質體的囊泡運輸為細胞間物質與訊息運輸的重要方式。本研究為了解遠端缺血-前制約訓練(Remote ischemia precondition, RIPC)是否透過Exosome增進對於缺血再灌流傷害(ischemia-reperfusion, I/R)傷害的保護,以細胞(in vitro)與動物(in vivo)的傷害模型,探討RIPC外質體對I/R injury的保護效果與機制。 材料與方法:以雄性大鼠(Wistar rat) 經由RIPC訓練後,以梯度離心收集其血中的Exosome 。本研究使用小鼠(C57BL6 mice)的部分肝臟缺血作為I/R injury的指標缺血模型。將RIPC Exosome或磷酸鹽緩衝生理食鹽水(PBS)經由脾臟注射後流至肝臟,確認RIPC Exosome是否可以減少部分肝臟缺血再灌流傷害。細胞學實驗使用大鼠肝細胞(Clone 9 cell),剝奪其氧及葡萄糖供應(oxygen-glucose deprivation,OGD)作為缺血再灌流傷害的模擬,並給PBS或是RIPC Exosome來確認RIPC Exosome組別是否有保護效果。 結果:注射RIPC-Exosome的肝臟缺血再灌流傷害小鼠比注射PBS的小鼠丙酮酸轉胺酶(GPT)更低,並且有顯著差異(P<0.05),而sham組GPT則遠比這兩組都來得低,有更顯著的差異(P<0.01)。給予RIPC Exosome的OGD Clone9肝細胞株組別,比給予PBS的組別存活率(MTT assay)更高(P<0.05),而Sham組存活率為最高,並與其他兩組有顯著差異(P<0.05)。在LDH傷害測試下,RIPC-Exosome組別比PBS組別顯示的傷害更低(P<0.05),而Sham組顯示的LDH數值最低,且與其他兩組有顯著差異(P<0.05)。RIPC-Exosome與Sham-Exosome經過次世代定序(Next-Generation Sequencing, NGS)分析,有24組基因序列有顯著差異(P<0.05),放入KEGG與GO基因庫搜尋預測路徑,則預測有metabolism, mTOR等路徑會與該24組基因的差異有相關性。 結論:本研究顯示了RIPC Exosome對於細胞學與動物的缺血再灌流傷害具有一定的保護效果,在肝功能指數與細胞死亡數值上與控制組有顯著差異(P<0.05)。而NGS也指出RIPC-Exosome與Sham-Exosome之間有24個基因出現顯著差異,並且預測與metabolism, mTOR等路徑有關。 | zh_TW |
dc.description.abstract | Background: Exosome vesicle transport has recently been discovered as an important way of transporting materials and messages between cells. This study is to understand whether remote ischemia precondition enhances the protection against ischemia-reperfusion (I/R) injury through the exosomes. Both in vitro and in vivo injury models were used to explore the protective effect and mechanism of RIPC-induced exosomes (RIPC-exosomes) on I/R injury. Materials and methods: The exosomes from the peripheral blood of male Wistar rats following RIPC were collected by gradient centrifugation. Partial liver I/R was established on C57BL6 mice as an index injury model. RIPC-exosome or phosphate buffered saline (PBS) was injected into the liver through the spleen to examine their protective effects on the liver I/R injury. Oxygen-glucose deprivation (OGD) was conducted on the Clone 9 cells (a rat liver cell line) to mimic I/R injury. RIPC-exosome group or PBS were added explore their protective effects on the clone 9 cells after OGD. Next-generation sequencing was used to detect the differential expressions of microRNAs in the exosomes with/with RIPC. Results: The serum level of pyruvate transaminase (GPT) was significantly lower in the RIPC-exosome group than that in the PBS group (641±32.462) (P<0.05) following partial liver I/R. The survival rate of Clone 9 cells following OGD, measured by MTT assay, was significantly higher in the RIPC-Exosomes group (0.604±0.02)than in the PBS group (o.449±0.01) (P<0.05). Under the Lactate dehydrogenase(LDH) test, RIPC-exosome group showed lower damage than the PBS group(P<0.05), the Sham group showed the lowest LDH level than the other two groups (P<0.05). NGS analysis showed 24 sets of gene sequences differentially expressed in RIPC-exosomes (P<0.05). The gene banks (KEGG and GO) search indicated that these genes were associated the metabolisms or mTOR pathways. Conclusion: This study shows that RIPC-exosome could mitigate the I/R-injuries. Next-Generation Sequencing (NGS) also find out that 24 differentially-expressed genes in RIPC-exosomes were related to the metabolism and mTOR pathways. | en |
dc.description.provenance | Made available in DSpace on 2021-07-10T21:37:30Z (GMT). No. of bitstreams: 1 U0001-1708202014495200.pdf: 2497369 bytes, checksum: be1c91f8de91bb4875001e01d2f8dc36 (MD5) Previous issue date: 2020 | en |
dc.description.tableofcontents | 目錄 口試委員審定書……………………………………………………………………i 誌謝…………………………………………………………………………………ii 目錄…………………………………………………………………………………iii 中文摘要……………………………………………………………………………iv 英文摘要……………………………………………………………………………v 壹、 緒論………………………………………………………………………… 1 一、缺血再灌流傷害……………………………………………………… 1 二、缺血再灌流傷害的機制……………………………………………… 1 三、低氧環境模擬缺血再灌流傷害……………………………………… 2 四、減緩缺血再灌流傷害的方法………………………………………… 2 五、前制約訓練…………………………………………………………… 3 六、外質體………………………………………………………………… 3 七、遠端缺血前制約訓練與外質體內小分子核糖核酸………………… 4 八、研究動機……………………………………………………………… 4 貳、 實驗材料…………………………………………………………………… 6 參、 實驗方法……………………………………………………………………10 肆、 實驗結果……………………………………………………………………16 伍、 討論…………………………………………………………………………19 陸、 結論…………………………………………………………………………21 柒、 附圖…………………………………………………………………………22 捌、 參考資料……………………………………………………………………36 | |
dc.language.iso | zh-TW | |
dc.title | 外質體在遠端缺血前制約訓練對肝臟缺血性傷害的保護效應與機制 | zh_TW |
dc.title | The Protective Effects of Remote Ischemia Preconditioning Exosome on Liver Ischemia-reperfusion Injury | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 賴亮全(Liang-Chuan Lai),龔秀妮(Hsiu-Ni Kung),張銘峰(Ming-Fong Chang) | |
dc.subject.keyword | 外質體,遠端缺血前制約訓練,次世代定序, | zh_TW |
dc.subject.keyword | exosome,remote ischemia precondition,Next Generation Sequencing, | en |
dc.relation.page | 41 | |
dc.identifier.doi | 10.6342/NTU202003754 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2020-08-18 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 解剖學暨細胞生物學研究所 | zh_TW |
顯示於系所單位: | 解剖學暨細胞生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-1708202014495200.pdf 目前未授權公開取用 | 2.44 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。